IDEAYA Biosciences (IDYA) Profit After Tax (2018 - 2026)

IDEAYA Biosciences has disclosed Profit After Tax across 9 years of filings, most recently posting -$98.5 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$98.5 million, down 36.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$140.1 million (up 54.39% YoY), and the FY2025 annual result was -$113.7 million, up 58.58% from the prior year.
• Profit After Tax came in at -$98.5 million for Q1 2026 at IDEAYA Biosciences, down from -$83.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $119.2 million in Q3 2025 to a low of -$130.3 million in Q4 2024.
• The 5-year median for Profit After Tax is -$34.0 million (2023), against an average of -$38.7 million.
• Across the five-year window, Profit After Tax tumbled 1799.07% in 2023 and jumped 330.11% in 2025, its largest moves.
• IDEAYA Biosciences' Profit After Tax stood at -$24.2 million in 2022, then tumbled by 40.3% to -$34.0 million in 2023, then slumped by 283.78% to -$130.3 million in 2024, then jumped by 36.1% to -$83.3 million in 2025, then dropped by 18.33% to -$98.5 million in 2026.
• The last three Profit After Tax figures came in at -$98.5 million (Q1 2026), -$83.3 million (Q4 2025), and $119.2 million (Q3 2025), per Business Quant data.